Characterization of Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of liver disease worldwide, and its incidence continues to grow. Current research suggests that compositional and functional changes in gut microbiota can contribute to liver damage; however, the issue is complex and far from clear. To address this, the gut microbiome of 16 MASLD patients was compared with two control groups: 16 healthy individuals and 6 patients with chronic active hepatitis C (CAH-C) using 16S rRNA next-generation Illumina MiSeq sequencing. Alpha diversity of the intestinal microbiome was significantly lower in the MASLD group (p = 0.0328) when compared to the CAH-C group, whereas no significant difference was observed relative to healthy controls. Additionally, there was a negative correlation between phylogenetic diversity (PD) and fibrosis stage (p = 0.0506; Spearman r = −0.5129) within the MASLD cohort. Gut microbiome diversity was not associated with gender, basic clinical or biochemical parameters, BMI, or steatosis and only the fibrosis score correlated with microbiota composition. Nevertheless, distinct quantitative variations at multiple taxonomic levels emerged when comparing MASLD patients with healthy individuals. The MASLD cohort exhibited a significant enrichment of Prevotellaceae, Veillonellaceae (Dialister, Megasphaera), Rikenellaceae, and a notable depletion of Bifidobacteriaceae, Lactobacillaceae, Lachnospiraceae, Ruminococcaceae, and Enterobacteriaceae.

Authors

Institutions

Publication Details

Journal
Molecules
Published
2026-11-17
DOI
https://doi.org/10.3390/molecules31224175
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Characterization of Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Joanna Jabłońska, Karol Perlejewski, Marek Radkowski, Iwona Bukowska‐Ośko et al.
7 links
Molecules
Gut microbiota and health
article

Characterization of Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Joanna Jabłońska, Karol Perlejewski, Marek Radkowski, Iwona Bukowska‐Ośko, Sylwia Osowska, Tomasz Laskus, Agnieszka Pollak, Urszula Lechowicz, Kamila Cortés-Fendorf, Mehmet Sinan Çoban, Paulina Emmel, Zainab Suleman
article en

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of liver disease worldwide, and its incidence continues to grow. Current research suggests that compositional and functional changes in gut microbiota can contribute to liver damage; however, the issue is complex and far from clear. To address this, the gut microbiome of 16 MASLD patients was compared with two control groups: 16 healthy individuals and 6 patients with chronic active hepatitis C (CAH-C) using 16S rRNA next-generation Illumina MiSeq sequencing. Alpha diversity of the intestinal microbiome was significantly lower in the MASLD group (p = 0.0328) when compared to the CAH-C group, whereas no significant difference was observed relative to healthy controls. Additionally, there was a negative correlation between phylogenetic diversity (PD) and fibrosis stage (p = 0.0506; Spearman r = −0.5129) within the MASLD cohort. Gut microbiome diversity was not associated with gender, basic clinical or biochemical parameters, BMI, or steatosis and only the fibrosis score correlated with microbiota composition. Nevertheless, distinct quantitative variations at multiple taxonomic levels emerged when comparing MASLD patients with healthy individuals. The MASLD cohort exhibited a significant enrichment of Prevotellaceae, Veillonellaceae (Dialister, Megasphaera), Rikenellaceae, and a notable depletion of Bifidobacteriaceae, Lactobacillaceae, Lachnospiraceae, Ruminococcaceae, and Enterobacteriaceae.

MoleculesVol. 31(22)
Medical University of Warsaw (PL), Harran University (TR)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon